About
Technology
Issues
FAQ
Links
Official Page
Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.